Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1986-5-14
|
pubmed:abstractText |
Apolipoprotein (apo) A-I is the principal protein component of high density lipoproteins and the major in vivo activator of lecithin-cholesterol acyltransferase. We have used the human hepatoma cell line, HepG2, as a model to examine the ability of estrogen to modulate hepatic synthesis of apo-A-I. Primer extension studies have demonstrated that the major transcriptional initiation site of the apo-A-I gene utilized in the hepatoma cells is the same as that used in human liver. The kinetics of induction of high- and low-affinity estrogen-binding sites, rates of secretion of apolipoproteins, and apo-A-I mRNA levels were examined following treatment of the cells with estrogen. Initial concentrations of 20 nM 17 beta-estradiol resulted in a 14-15-fold increase in the levels of high-affinity nuclear estrogen-binding sites within 8 h, while the level of low-affinity sites increased by only 10%. During the same period, the levels of apo-A-I mRNA and the rate of accumulation of the secreted protein increased by 55 and 50%, respectively. New steady state levels of apo-A-I mRNA and rates of accumulation of protein, approximately twice those in control cultures, were established within 24-48 h of exposure to hormone. Experiments with a 50-fold higher concentration of estrogen resulted in only an additional 10% increase in mRNA levels. The increase in mRNA levels following estrogen treatment was adequate to account for 85-90% of the elevation observed in the rate of accumulation of secreted apo-A-I. Comparison of the apo-A-I mRNA levels in HepG2 cells with those present in human liver revealed that the concentration of the mRNA was approximately 3-fold lower than that found in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins A,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
261
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5067-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3007489-Apolipoprotein A-I,
pubmed-meshheading:3007489-Apolipoproteins A,
pubmed-meshheading:3007489-Binding Sites,
pubmed-meshheading:3007489-Carcinoma, Hepatocellular,
pubmed-meshheading:3007489-Cell Line,
pubmed-meshheading:3007489-Cell Nucleus,
pubmed-meshheading:3007489-Estradiol,
pubmed-meshheading:3007489-Estrogens,
pubmed-meshheading:3007489-Humans,
pubmed-meshheading:3007489-Kinetics,
pubmed-meshheading:3007489-Liver,
pubmed-meshheading:3007489-Liver Neoplasms,
pubmed-meshheading:3007489-Lymphocytes,
pubmed-meshheading:3007489-Nucleic Acid Hybridization,
pubmed-meshheading:3007489-RNA, Messenger,
pubmed-meshheading:3007489-Transcription, Genetic
|
pubmed:year |
1986
|
pubmed:articleTitle |
Kinetics of estrogen-dependent modulation of apolipoprotein A-I synthesis in human hepatoma cells.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|